Diversity of Killer Cell Immunoglobulin-like Receptor Genes in Uveitis Associated with Autoimmune Diseases: Ankylosing Spondylitis and Behçet Disease

References

• Brown MA, Laval SH, Brophy S, Calin A. Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis. Ann Rheum Dis. 2000;59:883–886
   PubMed Web of Science ®Google Scholar
• Brown MA, Kennedy LG, MacGregor AJ, et al. Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum. 1997;40:1823–1828
   PubMed Web of Science ®Google Scholar
• Verity DH, Wallace GR, Vaughan RW, Stanford MR. Behcet's disease: from Hippocrates to the third millennium. Br J Ophthalmol. 2003;87:1175–1183
   PubMed Web of Science ®Google Scholar
• Mizuki N, Ota M, Katsuyama Y, et al. Association analysis between the MIC-A and HLA-B alleles in Japanese patients with Behcet's disease. Arthritis Rheum. 1999;42:1961–1966
   PubMed Web of Science ®Google Scholar
• Ahmad T, Wallace GR, James T, et al. Mapping the HLA association in Behcet's disease: a role for tumor necrosis factor polymorphisms? Arthritis Rheum. 2003;48:807–813
   PubMed Web of Science ®Google Scholar
• Direskeneli H, Saruhan-Direskeneli G. The role of heat shock proteins in Behcet's disease. Clin Exp Rheumatol. 2003;21:S44–S48
   PubMed Web of Science ®Google Scholar
• Hatemi G, Bahar H, Uysal S, et al. The pustular skin lesions in Behcet's syndrome are not sterile. Ann Rheum Dis. 2004;63:1450–1452
   PubMed Web of Science ®Google Scholar
• Calguneri M, Ertenli I, Kiraz S, et al. Effect of prophylactic benzathine penicillin on mucocutaneous symptoms of Behcet's disease. Dermatology. 1996;192:125–128
   PubMed Web of Science ®Google Scholar
• Kaklamani VG, Vaiopoulos G, Kaklamanis PG. Behcet's disease. Semin Arthritis Rheum. 1998;27:197–217
   PubMed Web of Science ®Google Scholar
• Lehner T. The role of heat shock protein, microbial and autoimmune agents in the aetiology of Behcet's disease. Int Rev Immunol. 1997;14:21–32
   PubMedGoogle Scholar
• Kibaroglu A, Eksioglu-Demiralp E, Akoglu T, Direskeneli H. T and NK cell subset changes with microbial extracts and human HSP60-derived peptides in Behcet's disease. Clin Exp Rheumatol. 2004;22:S59–S63
   PubMed Web of Science ®Google Scholar
• Scrivo R, Morrone S, Spadaro A, et al. Evaluation of degranulation and cytokine production in natural killer cells from spondyloarthritis patients at single-cell level. Cytometry B Clin Cytom. 2011;80:22–27
   PubMedGoogle Scholar
• Kaneko F, Takahashi Y, Muramatsu Y, Miura Y. Immunological studies on aphthous ulcer and erythema nodosum-like eruptions in Behcet's disease. Br J Dermatol. 1985;113:303–312
   PubMed Web of Science ®Google Scholar
• Kaneko F, Takahashi Y, Muramatsu R, et al. Natural killer cell numbers and function in peripheral lymphoid cells in Behcet's disease. Br J Dermatol. 1985;113:313–318
   PubMed Web of Science ®Google Scholar
• Jiao YL, Ma CY, Wang LC, et al. Polymorphisms of KIRs gene and HLA-C alleles in patients with ankylosing spondylitis: possible association with susceptibility to the disease. J Clin Immunol. 2008;28:343–349
   PubMed Web of Science ®Google Scholar
• Hamzaoui K, Ayed K, Hamza M, Touraine JL. Natural killer cells in Behcet's disease. Clin Exp Immunol. 1988;71:126–131
   PubMed Web of Science ®Google Scholar
• Eksioglu-Demiralp E, Direskeneli H, Ergun T, et al. Increased CD4+CD16+ and CD4+CD56+ T cell subsets in Behcet's disease. Rheumatol Int. 1999;19:23–26
   PubMedGoogle Scholar
• Lanier LL. NK cell receptors. Annu Rev Immunol. 1998;16:359–393
   PubMed Web of Science ®Google Scholar
• Carrington M, Martin MP. The impact of variation at the KIR gene cluster on human disease. Curr Top Microbiol Immunol. 2006;298:225–257
   PubMed Web of Science ®Google Scholar
• Boyton RJ, Altmann DM. Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease. Clin Exp Immunol. 2007;149:1–8
   PubMed Web of Science ®Google Scholar
• Suzuki Kurokawa M, Suzuki N. Behcet's disease. Clin Exp Med. 2004;4:10–20
   PubMed Web of Science ®Google Scholar
• Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease. Lancet. 1990;335:1078–1080
   Google Scholar
• van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum. 1984;27:361–368
   PubMed Web of Science ®Google Scholar
• Whang DH, Park H, Yoon JA, Park MH. Haplotype analysis of killer cell immunoglobulin-like receptor genes in 77 Korean families. Hum Immunol. 2005;66:146–154
   PubMed Web of Science ®Google Scholar
• Ashouri E, Farjadian S, Reed EF, et al. KIR gene content diversity in four Iranian populations. Immunogenetics. 2009;61:483–492
   PubMed Web of Science ®Google Scholar
• Chan AT, Kollnberger SD, Wedderburn LR, Bowness P. Expansion and enhanced survival of natural killer cells expressing the killer immunoglobulin-like receptor KIR3DL2 in spondylarthritis. Arthritis Rheum. 2005;52:3586–3595
   PubMedGoogle Scholar
• Diaz-Pena R, Vidal-Castineira JR, Alonso-Arias R, et al. Association of the KIR3DS1*013 and KIR3DL1*004 alleles with susceptibility to ankylosing spondylitis. Arthritis Rheum. 2010;62:1000–1006
   PubMed Web of Science ®Google Scholar
• Zvyagin IV, Mamedov IZ, Britanova OV, et al. Contribution of functional KIR3DL1 to ankylosing spondylitis. Cell Mol Immunol. 2010;7:471–476
   PubMed Web of Science ®Google Scholar
• Mousavi T, Poormoghim H, Moradi M, et al. Inhibitory killer cell immunoglobulin-like receptor KIR3DL1 in combination with HLA-B Bw4iso protect against ankylosing spondylitis. Iran J Immunol. 2010;7:88–95
   PubMedGoogle Scholar
• El Maghraoui A. Extra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implications. Eur J Intern Med. 2011;22:554–560
   PubMed Web of Science ®Google Scholar
• Levinson RD, Martin TM, Luo L, et al. Killer cell immunoglobulin-like receptors in HLA-B27-associated acute anterior uveitis, with and without axial spondyloarthropathy. Invest Ophthalmol Vis Sci. 2010;51:1505–1510
   PubMed Web of Science ®Google Scholar
• Middleton D, Meenagh A, Sleator C, et al. No association of KIR genes with Behcet's disease. Tissue Antigens. 2007;70:435–438
   PubMed Web of Science ®Google Scholar
• Saruhan-Direskeneli G, Uyar FA, Cefle A, et al. Expression of KIR and C-type lectin receptors in Behcet's disease. Rheumatology (Oxford). 2004;43:423–427
   PubMed Web of Science ®Google Scholar
• Colonna M, Borsellino G, Falco M, et al. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc Natl Acad Sci U S A. 1993;90:12000–12004
   PubMed Web of Science ®Google Scholar
• Wagtmann N, Biassoni R, Cantoni C, et al. Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. Immunity. 1995;2:439–449
   PubMed Web of Science ®Google Scholar
• Winter CC, Long EO. A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes. J Immunol. 1997;158:4026–4028
   PubMedGoogle Scholar
• Martin MP, Gao X, Lee JH, et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet. 2002;31:429–434
   PubMed Web of Science ®Google Scholar
• Stewart CA, Laugier-Anfossi F, Vely F, et al. Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. Proc Natl Acad Sci U S A. 2005;102:13224–13229
   PubMed Web of Science ®Google Scholar
• Kulkarni S, Martin MP, Carrington M. The yin and yang of HLA and KIR in human disease. Semin Immunol. 2008;20:343–352
   PubMed Web of Science ®Google Scholar
• Carr WH, Pando MJ, Parham P. KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand. J Immunol. 2005;175:5222–5229
   PubMed Web of Science ®Google Scholar
• Khakoo SI, Geller R, Shin S, et al. The D0 domain of KIR3D acts as a major histocompatibility complex class I binding enhancer. J Exp Med. 2002;196:911–921
   PubMedGoogle Scholar
• Evans DM, Spencer CC, Pointon JJ, et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet. 2011;43:761–767
   PubMed Web of Science ®Google Scholar
• Kollnberger S, Chan A, Sun MY, et al. Interaction of HLA-B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA-B27 heterotrimers, is independent of the sequence of bound peptide. Eur J Immunol. 2007;37:1313–1322
   PubMed Web of Science ®Google Scholar
• Bowness P, Ridley A, Shaw J, et al. Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis. J Immunol. 2011;186:2672–2680
   PubMed Web of Science ®Google Scholar
• Hirohata S, Kikuchi H. Behcet's disease. Arthritis Res Ther. 2003;5:139–146
   PubMed Web of Science ®Google Scholar
• Rajendram R, Rao NA. Molecular mechanisms in Behcet's disease. Br J Ophthalmol. 2003;87:1199–1200
   PubMedGoogle Scholar
• Mizuki N, Ohno S, Sato T, et al. Microsatellite polymorphism between the tumor necrosis factor and HLA-B genes in Behcet's disease. Hum Immunol. 1995;43:129–135
   PubMed Web of Science ®Google Scholar
• Mizuki N, Ota M, Katsuyama Y, et al. HLA-B*51 allele analysis by the PCR-SBT method and a strong association of HLA-B*5101 with Japanese patients with Behcet's disease. Tissue Antigens. 2001;58:181–184
   PubMed Web of Science ®Google Scholar
• Levinson RD, Du Z, Luo L, et al. Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals. Genes Immun. 2008;9:249–258
   PubMed Web of Science ®Google Scholar
• Yang KL, Chen IH, Hsiao CK, et al. Polymorphism of HLA-B27 in Taiwanese Chinese. Tissue Antigens. 2004;63:476–479
   PubMedGoogle Scholar
• Shahsavar F, Mousavi T, Azargon A, Entezami K. Association of KIR3DS1+HLA-B Bw4Ile80 combination with susceptibility to tuberculosis in Lur population of Iran. Iran J Immunol. 2012;9:39–47
   PubMed Web of Science ®Google Scholar
• Hirayasu K, Ohashi J, Kashiwase K, et al. Significant association of KIR2DL3-HLA-C1 combination with cerebral malaria and implications for co-evolution of KIR and HLA. PLoS Pathog. 2012;8:e1002565
   Google Scholar
• Suppiah V, Gaudieri S, Armstrong NJ, et al. IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European cohort: a cross-sectional study. PLoS Med. 2011;8:e1001092
   Google Scholar